Alando J. Ballantyne Resident Research Pilot Grant
American Head and Neck Society
All Regions
12/15/2008
$10,000

American Head and Neck Society Alando J. Ballantyne Resident Research Pilot Grant

For the best grant application by a resident in the U.S. or Canada. One year, non-renewable, $10,000, one available annually.

The purpose of this award is to support basic, translational, or clinical research projects in head and neck
oncology. Clinical or translational research studies are strongly encouraged and should be specifically
related to the prevention, diagnosis, treatment, outcomes, or pathophysiology of head and neck
neoplastic disease. The Alando J. Ballantyne Resident Research Pilot Grant memorializes Alando J.
Ballantyne, M.D., a giving teacher, dedicated surgeon, and a devoted husband and father.
ELIGIBILITY
This grant is open to resident in U.S. or Canadian training programs. Previous AHNS or AAO-HNS
Foundation research grant recipients are eligible to compete for this grant. However, candidates who
have successfully obtained funding from a private or federal funding agency for the same research are
ineligible. Candidates who have applied for support of the same research from other funding sources, and
who are notified of an award from both another agency and from AHNS must choose only one of the
awards.
CONDITIONS
Research supported by this award should be specifically directed toward the pathogenesis,
pathophysiology, diagnosis, prevention, or treatment of head and neck neoplastic disease, and may be
either basic or clinical/translational in approach. While not specifically required, proposals which aim to
introduce new knowledge and methodology from other disciplines to research in head and neck disease,
or which demonstrate collaborative effort with members of other related disciplines are encouraged.
Projects must be designed so as to yield useful information within the period of award, but priority will be
given to projects that are also innovative with promise to develop into new long-range or expanded
research programs capable of attracting funding from other sources. The grant application must be
accompanied by letters of support from the Chair of the candidate’s academic department and from the
principal scientific advisor or mentor. These letters are to indicate a general level of support of the
applicant, the fact that the Department will make time, space, and other resources accessible for
completion of the project, and that the applicant will have appropriate supervision/support throughout the
period of the grant. Applicants must obtain letters of support/understanding from all key personnel on the
project.
TERMS
1. Amount: $10,000 maximum
2. Period: 12 months, non-renewable

All applicants must submit a Letter of Intent online no later than midnight Eastern Standard Time
December 15. The letter of intent includes the title of the project, the principal investigator, and an
abstract of the work. This will facilitate planning review requirements.

Medical Resident
Pilot Grant--Head and Neck Oncology
American Head and Neck Society
All Regions
12/15/2008
$10,000

American Head and Neck Society Pilot Grant

Open to Medical Students, residents, PhD, and junior faculty residing in the U.S. and Canada to support basic, translational, or clinical research projects in head and neck oncology. One year, $10,000, one available annually.

The purpose of this award is to support basic, translational, or clinical research projects in head and neck
oncology. Clinical or translational research studies are strongly encouraged and should be specifically
related to the prevention, diagnosis, treatment, outcomes, or pathophysiology of head and neck
neoplastic disease.
ELIGIBILITY
Candidates for this award should reside in the U.S. or Canada, be medical students, residents, Ph.D.s or
faculty members at the rank of associate professor or below. Previous AHNS or AAO-HNS Foundation
research grant recipients are eligible to compete for this grant. However, candidates who have
successfully obtained funding from a private or federal funding agency for the same research are
ineligible. Candidates who have applied for support of the same research from other funding sources, and
who are notified of an award from both another agency and from AHNS must choose only one of the
awards.
CONDITIONS
Research supported by this award should be specifically directed toward the pathogenesis,
pathophysiology, diagnosis, prevention, or treatment of head and neck neoplastic disease, and may be
either basic or clinical/translational in approach. While not specifically required, proposals which aim to
introduce new knowledge and methodology from other disciplines to research in head and neck disease,
or which demonstrate collaborative effort with members of other related disciplines are encouraged.
Projects must be designed so as to yield useful information within the period of award, but priority will be
given to projects that are also innovative with promise to develop into new long-range or expanded
research programs capable of attracting funding from other sources.
The grant application must be accompanied by letters of support from the Chair of the candidate’s
academic department and from the principal scientific advisor or mentor. These letters are to indicate a
general level of support of the applicant, the fact that the Department will make time, space, and other
resources accessible for completion of the project, and that the applicant will have appropriate
supervision/support throughout the period of the grant. Applicants must obtain letters of
support/understanding from all key personnel on the project.
TERMS
1. Amount: $10,000 maximum
2. Period: One year, non-renewable

All applicants must submit a Letter of Intent online no later than midnight Eastern Standard Time
December 15. The letter of intent includes the title of the project, the principal investigator, and an
abstract of the work. This will facilitate planning review requirements.

Junior Faculty, Junior Investigator, Junior Researcher, Junior Scientist, Medical Resident, Medical Student, Oncologist, Physician Researcher, Young Investigator, Young Scientist
UICC Yamagiwa-Yoshida Memorial international study grants
International Union Against Cancer
All Regions
01/15/2009
$10,000

UICC Yamagiwa-Yoshida Memorial international study grants

Target candidates Investigators, clinicians, epidemiologists, public health professionals
Duration 3 months
Extension Up to 3 months with funding secured by the Fellow from other sources and at no cost to UICC
Available 14-16 per year
Average value US$10,000 each
Application closing dates 15 January and 1 July
Notification of result April and October

Note: This is not a clinical training fellowship

Objectives

to initiate, set up or pursue bilateral cancer research projects with collaborating investigators abroad
to exchange and exploit complementary skills and material
to receive training in advanced experimental research methods and techniques

Profile of eligible candidates

appropriate scientific or medical qualifications and a minimum of two years postdoctoral experience
active engagement in cancer research
recent publications in the international peer-reviewed literature

Research plan

basic, translational or applied cancer research
Prevention-oriented projects are especially encouraged

Twice-yearly competitive selections
are conducted by an international panel of experts
based on the scientific evaluation of the research plan the experience and qualifications of the candidate
the suitability of the host organization and host supervisor

appropriate duration
the availability of appropriate facilities and resources to apply and disseminate the acquired skills upon return to the home organization

To contact UICC, write to us at the following address:

International Union Against Cancer (UICC)
62 route de Frontenex
1207 Geneva, Switzerland

Telephone +41 22 809 1811
Fax +41 22 809 1810

Behavioral Scientist, Cancer Registrar, Oncologist, Oncology Nurse, Physician Researcher, Public Health Expert, Public Health Worker, Scientist
Cancer Public Education Project Grant
Oncology Nursing Society Foundation
All Regions
12/01/2008
$5,000

Oncology Nursing Society Foundation Cancer Public Education Project Grant

Awards: Up to $5,000 available for funding.

Purpose: To enhance the public's knowledge and awareness of cancer prevention, detection, and treatment modalities.

Selection Criteria: The candidate must have a current license to practice as a registered nurse and must have an interest in and commitment to oncology nursing. The major focus of the project should be some aspect of cancer public education.

Application deadline: December 1, 2008

ONS Foundation
125 Enterprise Drive
Pittsburgh, PA 15275
866-257-4ONS
412-859-6100
877-369-5497 (toll free fax)
412-859-6163 (fax)
E-mail: foundation@ons.org
Web site: www.onsfoundation.org

Oncology Nurse, Public Health Expert, Public Health Worker
AACR Award for Outstanding Achievement in Chemistry in Cancer Research
American Association for Cancer Research
All Regions
10/15/2008
$10,000

AACR Award for Outstanding Achievement in Chemistry in Cancer Research
Nominations for the 2009 Award will open in September 2008.
Nomination deadline: Wednesday, October 15, 2008 

The Award & Lecture

The AACR and its Chemistry in Cancer Research Working Group established this Award in 2007 to recognize the importance of chemistry to advancements in cancer research. The Award will be given for outstanding, novel, and significant chemistry research, which has led to important contributions to the fields of basic cancer research; translational cancer research; cancer diagnosis; the prevention of cancer; or the treatment of patients with cancer. Such research may include, but is not limited to, drug discovery and design; structural biology; proteomics, metabolomics and biological mass spectrometry; chemical aspects of carcinogenesis; imaging agents and radiotherapeutics; and chemical biology.

The winner of the 3rd Annual AACR Award for Outstanding Achievement in Chemistry in Cancer Research will give a 50-minute lecture during the AACR Annual Meeting 2009 in Denver, CO, USA (April 18-22, 2009), and will receive a commemorative plaque and $10,000 honorarium.

Eligibility Criteria
Candidacy is open to all researchers who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry, or government.
The Award will be presented to an individual investigator. Two or more individuals may be selected to share the Award when their investigations are closed related in subject matter and have resulted in work worthy of an award.
Institutions or organizations are not eligible for the Award.
Selection of the Award winner will be made on the outstanding quality, novelty, and significance of the candidates' chemistry research and its important contributions to cancer research. No regard will be given to race, gender, nationality, geographic location, or religious or political views.
Prior recipients of the AACR-Bruce F. Cain Memorial Award are not eligible to be nominated for research previously recognized by the Cain Award.

Nomination Process
Nominations may be made via letter from any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Candidates may not nominate themselves.

Nomination letters must be sent electronically to the AACR by Wednesday, October 15, 2008 at 4:00 p.m., United States Eastern Time. Preferred file formats are *.doc, *.pdf. Your nomination is not considered fully submitted until you receive a confirmation e-mail from the AACR; confirmations will be sent within 2 business days.

The nomination letter must be addressed to the Selection Committee; be written in English; and not exceed 1,000 words. The content should include the following:

the name of the AACR Award for which the candidate is being nominated;

a brief statement of no more than 50-words summarizing the candidate's cancer research accomplishment(s) for which he or she is being nominated;

a concise description of the candidate's outstanding cancer research accomplishments in the fields of epidemiology, biomarkers, and prevention, with the publications supporting these accomplishments directly referenced within the letter; and
a concise description of the impact of these accomplishments on the field.
Nominators are asked to maintain the confidentiality of the nomination process and to refrain from informing the candidate about the nomination.

There is no restriction on the number of candidates that may be nominated by any individual scientist. There is no restriction on the number of nominators that may write nomination letters or that may sign a single nomination letter on behalf of a candidate.

Selection
Candidates will be considered by a Selection Committee of international cancer leaders appointed by the President of the AACR. The Committee will consider all nominations as they have been submitted; the Committee may not combine submitted nominations, add a new candidate to a submitted nomination, or otherwise make alterations to the submitted nominations. After careful deliberations by the Committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the Award winner will be made on the basis of the candidate's outstanding, novel, and significant chemistry research related to cancer. No regard will be given to age, race, gender, nationality, geographic location, or religious or political views.

The winner of the 3rd Annual AACR-CICR Award will be announced in January 2009.

Supporter
Generously supported by GlaxoSmithKline.

Questions?
Monique P. Eversley, Program Associate
+1 (267) 646-0576; monique.eversley@aacr.org

American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA 19106-4404

Chemist, Medicinal Chemist, Oncologist, Physician Researcher, Scientist
AACR Princess Takamatsu Memorial Lectureship
American Association for Cancer Research
All Regions
10/15/2008
$10,000

AACR Princess Takamatsu Memorial Lectureship

The Lectureship
The AACR Princess Takamatsu Memorial Lectureship was established and first presented in 2007 in honor of the late Princess Takamatsu of Japan. During her extraordinary life, Her Imperial Highness Princess Takamatsu expended tremendous efforts toward the public and humanitarian cause of the eradication of cancer. She is regarded as an honored and respected figure in Japan, the United States, and within the international cancer research community as a whole.

This Lectureship will recognize an individual scientist whose novel and significant work has had or may have a far-reaching impact on the detection, diagnosis, treatment, or prevention of cancer, and who embodies the dedication of the Princess to multinational collaborations. The recipient of the 2nd Annual Lectureship will present a major, 50-minute lecture during the AACR Annual Meeting 2009 in Denver, CO, USA (April 18-22, 2009).

The Lecturer will receive an unrestricted cash award of US$10,000, support to attend the AACR Annual Meeting, and a commemorative item serving as tangible witness to the singular honor of his/her selection.

Eligibility Criteria
Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry, or government.

The Lectureship will be presented to an individual investigator.

Institutions or organizations are not eligible for the Lectureship.

Nomination Process
Nominations for the Lectureship must be submitted electronically to awards@aacr.org no later than 4:00 p.m. US Eastern Time on October 15, 2008. Paper nominations will not be accepted.

Nominations may be made by any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science.

Candidates may not nominate themselves.

Nominators are asked to maintain the confidentiality of the nomination process and to refrain from informing the candidate about the nomination.

There is no restriction on the number of candidates nominated by any institution or nominator.

Nomination Materials
The following materials must be sent electronically to the AACR as noted above. Preferred file formats are *.doc, *.pdf. Your nomination is not considered fully submitted until you receive a confirmation e-mail from the AACR; confirmations will be sent within 2 business days.

1) Letter of Recommendation. The letter of recommendation must:

be addressed to the Selection Committee; be written in English; and not exceed 1,000 words;

specify the AACR Lectureship for which the candidate is being nominated; and

describe the candidate's novel and significant work in cancer research and dedication to multinational collaborations, with the publications supporting these accomplishments directly referenced within the letter.
2) Candidate's CV. The candidate's curriculum vitae in English, including a complete list of the candidate's publications.
3) Summary Statement. A statement of no more than 50 words summarizing the candidate's accomplishments for which he or she is being nominated.

Selection
Candidates will be considered by a Selection Committee of international cancer leaders appointed by the President of the AACR. Selection of the Lecturer will be made on the basis of the novel and significant work, its far-reaching impact on the detection, diagnosis, treatment, or prevention of cancer, and his or her embodiment of the dedication of the Princess to multinational collaborations. No regard will be given to age, race, gender, nationality, geographic location, or religious or political views. After careful deliberations by the Committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision.

Supporter
Generously supported by Princess Takamatsu Cancer Research Foundation (Japan).

Questions?
Monique P. Eversley, Program Associate
+1 (267) 646-0576; monique.eversley@aacr.org

American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA 19106-4404

Distinguished Investigator, Distinguished Scholar, Distinguished Scientist, Established Investigator, Oncologist, Physician Researcher, Scientist, Senior Investigator, Senior Researcher
American Society of Clinical Oncology Cancer Foundation Young Investigator Award
American Society of Clinical Oncology Cancer Foundation
All Regions
10/30/2008
$50,000

American Society of Clinical Oncology Cancer Foundation Young Investigator Award

The Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this award is to fund physicians during the transition from a fellowship program to a faculty appointment. Priority consideration will be given to proposals that include patient-oriented and, ultimately, clinical research.

Since many awards are supported with restricted grants from outside organizations, we are particularly interested in identifying young researchers working in the following subspecialties and emerging disciplines:
Breast Cancer
Cancer Survivorship
Geriatric Oncology
Health Disparities
Kidney Cancer
Multiple Myeloma
Ovarian Cancer
Pancreatic Cancer
Sarcoma
Survivorship
Young Adult Cancer

However, The ASCO Cancer Foundation welcomes application submissions in all oncology subspecialties.

The 2009 online applications are now open!

APPLY NOW for the 2009 PROGRAM

Online Applications will close at 5:00 pm (EST) on October 30, 2008.

If you have any questions, please contact grants@asco.org.

Mission

The Young Investigator Award is intended to support proposals with a clinical research focus. ASCO’s definition of clinical research is “hypothesis-driven research that employs measurements in whole patients or normal human subjects, in conjunction with laboratory measurements as appropriate, on the subjects of clinical biology, natural history, prevention, screening, diagnosis, therapy, or epidemiology of neoplastic disease” (Journal of Clinical Oncology, Vol. 14, No. 2, 1996 pp. 666-670). In Young Investigator Award proposals, preclinical in vitro +/- animal studies are acceptable as long as the outcome of these studies would ultimately lead to patient-oriented clinical research.

Eligibility

The recipient must be a physician (MD or DO) who, at the time of grant award (July 2009), is in the final year of his/her final subspecialty training program or in the first year post his/her final subspecialty training
An institutional commitment for a faculty appointment at the time of grant submission is not required, but the applicant should be working in an oncology laboratory or clinical research setting
The sponsoring facility must be an academic medical institution. The primary mentor must be in the candidate’s proposed research field, and must assume responsibility and provide guidance for the research.
If the mentor is not an active ASCO member, a supporting letter from an ASCO member must be included
Applicants should be planning an investigative career in clinical oncology
The applicant must either be a member of ASCO or submit a membership application with the grant application
The applicant should spend at least 60 – 75% of his/her time in research during the award period
An MD, PhD is eligible if the terminal degree is completed prior to the start of the grant period

Eligible physicians may submit only one application to The ASCO Cancer Foundation per year
The ASCO Cancer Foundation Grants Selection Committee reserves the right to evaluate and determine applicants’ eligibility based on the information and justifications included in the application materials.

Award Term

The award is for a one-year period, July 1, 2009 – June 30, 2010, for a total amount of $50,000. Payments are made to the applicant’s institution in two equal installments on July 1 and January 1. The award is comprised of $46,000 to support the grant project, $1,500 for travel related to the project, including the ASCO Annual Meeting, and $2,500 for the institution to help defray costs related to the administration of the project.

Young Investigator, Oncologist, Physician Researcher, Young Scientist
American Society of Clinical Oncology Cancer Foundation Career Development Award
American Society of Clinical Oncology Cancer Foundation
All Regions
10/30/2008
$200,000

American Society of Clinical Oncology Cancer Foundation Career Development Award

The Career Development Award (CDA) provides funding to clinical investigators who have received their initial faculty appointment to establish an independent clinical cancer research program.

Since many awards are supported with restricted grants from outside organizations, we are particularly interested in identifying young researchers working in the following subspecialties and emerging disciplines:
Breast Cancer
Cancer Survivorship
Geriatric Oncology
Health Disparities
Kidney Cancer
Multiple Myeloma
Ovarian Cancer
Pancreatic Cancer
Sarcoma
Survivorship
Young Adult Cancer

However, The ASCO Cancer Foundation welcomes application submissions in all oncology subspecialties.

The 2009 online applications are now open!

APPLY NOW for the 2009 PROGRAM

Online Applications will close at 5:00 pm (EST) on October 30, 2008.

If you have any questions, please contact grants@asco.org.

Mission

The Career Development Award is intended to support proposals with a clinical research focus. ASCO’s definition of clinical research is "hypothesis-driven research that employs measurements in whole patients or normal human subjects, in conjunction with laboratory measurements as appropriate, on the subjects of clinical biology, natural history, prevention, screening, diagnosis, therapy, or epidemiology of neoplastic disease” (Journal of Clinical Oncology, Vol. 14, No. 2, 1996 pp. 666-670). Proposals must have a patient-oriented focus including a clinical research study involving human subjects. Proposals with a predominant focus on in vitro or animal studies (even if clinically relevant) are not allowed.

Eligibility

At the time of the grant award (July 2009), the applicant must meet the following criteria:
Be a physician (MD, DO, or international equivalent with explanation)
Be in the second, third or fourth year of a full-time, primary faculty appointment in a clinical department at an academic medical institution
Have completed his/her final subspecialty training within the past four years. Special considerations are allowed (such as military service, family leave, etc) if written justification is included in the application.
Have an institutional commitment as a faculty member in a clinical oncology program
Have completed productive postdoctoral research and demonstrated the ability to undertake independent investigator-initiated clinical research
Be a member of ASCO or submit a membership application with the grant application
Spend more than 50% of his/her time in research during the award period
Have a mentor from his/her institution and provide an institutional letter of support. If the mentor is not an active ASCO member, a supporting letter from an active ASCO member must be included.
Eligible physicians may submit only one application to The ASCO Cancer Foundation per year
Applicants with existing career development awards (such as a K23, K08, or any other type of career development award) will not be considered for funding
The ASCO Cancer Foundation Grants Selection Committee reserves the right to evaluate and determine applicants' eligibility based on the information and justifications included in the application materials.

Award Terms

The total award amount is $200,000 paid in three annual increments of $66,666 on July 1. The award is comprised of $59,966 per year for support of the project, $2,500 per year for travel including the ASCO Annual Meeting, and $4,200 per year for the institution to help defray its costs related to the administration of the project. The award period begins July 1, 2009 and concludes June 30, 2012.

Oncologist, Physician Researcher, Junior Faculty, Medical School Faculty
Research Proposals Directed at Poor and Underserved Populations
American Cancer Society
All Regions
10/15/2008
$400,000
Research Proposals Directed at Poor and Underserved Populations
Program Director: Ronit Elk, PhD
American Cancer Society
250 Williams Street, NW
Atlanta, GA 30303-1002
Telephone: (404) 417-5957
Fax: (404) 321-4669
Email: ronit.elk@cancer.org

Despite the steady overall decline in cancer incidence and mortality rates, the incidence of many cancers in poor and underserved populations is higher, and morbidity and mortality are often greater. The American Cancer Society is committed to reducing disparities and alleviating the disproportionate cancer burden borne by many underserved populations, and has designated this a high-priority area. The Extramural Grants Department of the Research Department has launched a special initiative to decrease disparities. Funds have been set aside (up to 10% of the research budget) to support research that addresses the disparity in cancer morbidity and mortality in poor and underserved populations. This initiative includes research that addresses a variety of clinical, cancer control, behavioral, epidemiologic, health policy, health services and basic science questions.

Application Mechanisms: Applications will be accepted via one of the following three mechanisms: (1) Postdoctoral Fellowships; (2) Mentored Research Scholar Grants and (3) Research Scholar Grants, as described below:

Postdoctoral Fellowships
This mechanism provides support for the training of researchers who have received a doctorate, providing initial funding leading to an independent career in cancer research. Awards are made for up to three years with progressive stipends of $40,000, $42,000 and $44,000 per year, plus a $4,000 per year institutional allowance. Please refer to Postdoctoral Fellowships Policies and Instructions(PDF). Please Note: Eligibility criteria, budget and number of years of the award in this special initiative are the same as for those of the regular Postdoctoral Fellowship, as are instructions for submitting the application.

Mentored Research Scholar Grants in Applied and Clinical Research
This mechanism provides support for mentored research and training by full-time faculty to junior faculty, typically within the first four years of their first independent appointment. The goal is for these beginning investigators to become independent researchers in clinical research and in cancer control and prevention research. Awards are made for up to five years, with a budget of $135,000 per year (direct costs), plus 8% allowable indirect costs. Up to $10,000 per year for the mentor is included in the $135,000. Please refer to Instructions and Policies for Mentored Research Scholar Grants in Applied and Clinical Research. Please Note: Eligibility criteria, budget and number of years of the award in this special initiative are the same as for those of the regular Mentored Research Scholar Grants in Applied and Clinical Research, as are instructions for submitting the application.

Research Scholar Grants A. In Basic, Preclinical and Epidemiology Research (includes Senior Investigators for this Special Initiative.):
This mechanism supports investigator-initiated basic, preclinical, clinical, and epidemiologic research projects. Independent investigators at any stage of their academic career may apply, although senior investigators are strongly encouraged to include junior investigators on the grant. Awards are made for up to four years with a budget of up to $200,000 (direct costs), plus 20% allowable indirect costs. Once awarded these grants may be renewed once via competitive renewal. Please refer to Instructions and Policies for Research Scholar Grants in Basic, Preclinical and Epidemiology Research. Please Note: Eligibility criteria, budget and renewal status in this special initiative differ from those of the regular Research Scholar Grants in Basic, Preclinical and Epidemiology. However, instructions for submitting the application remain the same.

Research Scholar Grants B. In Health Policy and Health Services Research:
This mechanism supports investigator-initiated research projects centered on health services and health policy research. Independent investigators at any stage of their academic career may apply, although senior investigators are strongly encouraged to include junior investigators on the grant. Awards are made for up to four years with a budget of $200,000 per year (direct costs), plus 20% allowable indirect costs. Once awarded, these grants may be renewed once via competitive renewal. Please refer to Instructions and Policies for Research Scholar Grants in Cancer Control: Health Services and Health Policy Research. Please Note: Eligibility criteria, budget and renewal status in this special initiative differ from those of the regular Research Scholar Grants in Cancer Control: Health Services and Health Policy Research. However, instructions for submitting the application are the same.

Research Scholar Grants C. In Psychosocial and Behavioral Research:
This mechanism supports investigator-initiated research projects centered on health policy research. For this initiative, independent investigators at any stage of their academic career may apply, although senior investigators are strongly encouraged to include junior investigators on the grant. For this initiative and for research focusing on psychosocial and behavioral research only, awards are made for up to five years with a budget of $400,000 per year (direct costs), plus 20% allowable indirect costs. Once awarded, these grants may be renewed once via competitive renewal. Please refer to Instructions and Policies for Research Scholar Grants in Psychosocial and Behavioral Research. Please Note: Eligibility criteria, budget and renewal status in this special initiative differ from those of the regular Research Scholar Grants in Psychosocial and Behavioral Research. However, instructions for submitting the application are the same.

Application deadline: April 1 and October 15.

Questions? Please email Ronit Elk, PhD at ronit.elk@cancer.org
Behavioral Scientist, Health Services Researcher, Social Scientist, Academic
RFA (2008): Canary Foundation/ACS Postdoctoral Fellowship in the Early Detection of Cancer for 2009
Canary Foundation/American Cancer Society
All Regions
10/15/2008
$126,000
RFA (2008): Canary Foundation/ACS Postdoctoral Fellowship in the Early Detection of Cancer for 2009
CANARY FOUNDATION AND THE AMERICAN CANCER SOCIETY ANNOUNCE A NEW CYCLE OF POSTDOCTORAL FELLOWSHIP AWARDS IN THE EARLY DETECTION OF CANCER FOR 2009

Technical developments in the rapidly advancing fields of genomics, proteomics, metabolomics, and imaging are transforming how patients and physicians evaluate risk, prevention, detection, and the treatment of cancer. These emerging technologies will lead to rapid, cost-effective, and coordinated evaluation of an individual's DNA sequence, complex patterns of RNA and protein expression, and metabolic regualation. This in turn, presents exciting opportunities to translate such knowledge into clinical management.

The Canary Foundation, in partnership with the American Cancer Society, is extending its postdoctoral fellowship program focused on
studies towards development of strategies for the early detection of cancer.. Research should be directed at new approaches to improve clinical methods for the detection of primary tumors and/or metastases, including, but not limited to research focused in the following areas:

Minimally invasive strategies for early detection
Biomarker identification or discovery
Imaging, including novel molecular imaging strategies
Segmentation of early stage disease according to prognosis

The projects that will be funded are expected to have a direct impact on the early detection of cancer or to provide a clear conceptual or experimental foundation for the future development of methods for early detection.

Awards will be 3 years in duration with progressive stipends of $40,000, $42,000, and $44,000 per year, plus $4,000 per year for fellowship allowance. It is anticipated that up to 5 awards will be made. Applications will only be accepted from scientists who, at the time of application, have had no more than 2 years of research experience beyond their terminal degree (MD or PhD). Applicants must be US citizens or permanent residents working with an accomplished mentor at a non-profit institution. Awardees will be asked to attend the Canary Foundation Early Detection Symposium June 16, 17 and 18, 2009 and to continue to the online Canary Journal project.

Deadline: Complete application: October 15, 2008. For additional information regarding program policies or to obtain an application, please refer to the ACS website: Access Electronic Grant application process at proposalCENTRAL.

To learn about the Canary Foundation, please visit canaryfoundation.org.

For specific inquiries, please contact:

Michael H. Melner, PhD
Scientific Program Director
American Cancer Society, Inc.
404-327-6528
michael.melner@cancer.org
Imaging Professional, Molecular Biologist , Oncologist, Physician Researcher

2next